How to treat angiosarcoma | Sarcoma Talk #11 with Michael J. Wagner

3 Views
Published
In this Sarcoma Talk, Dr. Michael J. Wagner, Medical Oncologist at Dana-Farber Cancer Institute, joins host Shushan Hovsepyan. Dr. Wagner discusses the latest advancements in angiosarcoma treatment, highlighting the challenges of diagnosing this rare cancer. He explores the molecular differences between cutaneous, hepatic, and breast angiosarcomas, and shares insights into new therapeutic strategies and clinical trials.

#Cancer #SarcomaTalk #OncoDaily #SarcomaResearch #Immunotherapy #CancerResearch #CancerTreatment # MichaelWagner #ClinicalTrials #ShushanHovsepyan #Angiosarcoma #CancerBreakthroughs #PrecisionOncology #CancerImmunotherapy

00:00 Introduction to Angiosarcoma
02:30 Locations and molecular differences: skin, liver, and breast
05:12 Scalp and face tumors linked to UV exposure; responsive to immunotherapy
07:45 Diagnostic challenges and the need for expert pathology
09:32 Treatment options
12:10 Ongoing research and future directions
13:25 Closing thoughts on advances and challenges in angiosarcoma treatment

SUBSCRIBE to get the latest #oncodaily https://www.youtube.com/@OncoDailyTV

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn: https://linkedin.com/company/oncodaily
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram: https://www.instagram.com/oncodailynews/
Follow OncoDaily on TikTok: https://www.tiktok.com/@oncodaily
Like OncoDaily on Facebook: https://www.facebook.com/oncodaily/

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
Category
Oncology
Be the first to comment